the past decade has revealed that both bacterial and viral pathogens use effectors to interfere with or manipulate the ubiquitination system [6] . This involves a large number of Bacterially encoded E3 ubiquitin Ligases (BELs). There are multiple RING-type BELs, HECT-like BELs, and even BELs that bear no resemblance to known eukaryotic ubiquitin ligases ( Figure 1A ).
BELs That RING
The first identification of a bacterially encoded E3 ubiquitin ligase was AvrPtoB from the plant pathogen Pseudomonas syringae pv. tomato (Pst) [7] . Plants use resistance proteins (R proteins) that recognize effectors from would-be pathogens. When R proteins engage bacterial effectors, they initiate an Effector Triggered Immune (ETI) response that prevents systemic disease [8] . AvrPtoB effectors from some P. syringae strains are recognized by the R protein Fen that initiates ETI. Although Pst AvrPtoB shared no sequence similarity to proteins of known function, the crystal structure revealed striking structural conservation with RING E3s [9] . AvrPtoB was shown to possess E3 ligase activity in vitro and to suppress ETI, demonstrating a role in pathogenesis [7] . AvrPtoB disrupts ETI by targeting Fen and Pto kinases for ubiquitination [10] .
Bioinformatic approaches revealed that Legionella pneumophila encodes a number of F-box containing proteins [11] . Studies have demonstrated that these F-Box proteins function in infected cells as components of CRLs. In this case, BEL activity generates free amino acids that serve as fuel for Legionella growth inside infected cells [12] . Legionella encodes a BEL, LubX, that contains multiple U-boxes [13] . LubX targets another Legionella effector, the kinase SidH, for destruction, establishing LubX as a ''metaeffector'' that may act to coordinate spatiotemporal control of the effector repertoire within the host cell [14] . Thus, the targets of BELs should not necessarily be assumed to be host-encoded proteins.
One abundant class of RING-type E3s is the NleG family, encoded in enterohaemorrhagic Escherichia coli and Citrobacter rodentium [15] . NleGs were identified using NMR structural studies. Although no sequence similarity exists, the NleGs show close structural similarity to RING-type U-box proteins. As yet, no phenotypes have been associated with nleG mutants, but their large number points toward an important role.
HECT-Like BELs
Discovery of HECT-like BELs followed a similar path as did AvrPtoB and NleG, driven in part by structural biology. The closely related effectors SopA, from Salmonella enterica, and NleL, from enterpathogenic E. coli, were both known to play a role in dampening host inflammation upon infection. While these effectors share no sequence homology to proteins of known function, Zhou and coworkers demonstrated that SopA functioned as a HECT-like enzyme [16] . The mechanisms of ubiquitin transfer had an absolute requirement for a catalytic Cys residue, and SopA was shown to form a Cys,Ub thioester intermediate. These data suggest a mechanism of Ub transfer similar in mechanism to that of HECT enzymes, but it is clear that there will be significant differences as well. First, the proposed substratebinding domain is adjacent to the E2 binding site, in contrast to what has been proposed for eukaryotic HECTs [17] . Secondly, SopA and NleL interact with the same region of Ubc8 as do mammalian HECT or RING domain E3s, but differ in the precise E2 residues that are required for BEL activity [18] .
BELs That Are NELs-And More…
Shigella spp. use T3SS effectors to cause shigellosis. The most abundant effectors produced by Shigella upon contact with human cells are the IpaH proteins, a class of proteins that exist in many gram-negative pathogens of animals and plants [19] . Their N-terminal domain consists of a series of leucine rich repeat (LRR) domains that share high similarity with YopM from Yersinia spp. [20] . The C-terminal domain is highly conserved among IpaH family members. Using yeast as a surrogate genetic system, IpaH9.8 was shown to possess E3 ubiquitin ligase activity and destroy the MAPKK Ste7 in a proteasome-dependent manner [19] . The IpaH family member SspH1 from Salmonella was shown to also be an E3 ligase that could ubiquitinate a known mammalian interacting protein, PKN1, in vitro [19] . Earlier studies had already shown that substrate specificity was dictated by the LRR domains [21] . The ability to ubiquitinate substrates was shown to rely on a Cys residue that is invariant among the more than 50 proteins that comprise the IpaH family [19] . Again, the IpaH family members shared no sequence similarity to proteins of known function. The crystal structure was solved independently by three groups and revealed that the catalytic domain was entirely alpha helical, had no resemblance to other E3 enzymes, and was coined the NEL domain (novel E3 ligase) [22] [23] [24] . Similar to HECTs, NEL domains use the invariant Cys residue to form a thioester linkage with Ub [22, 23] . Mutations in E2 enzymes that ablate activity towards RING or HECT domain E3s were shown to be fully functional for Ub transfer to NELs, suggesting a novel E2-E3 interaction [22] . Elegant structural studies showed that NEL domain BELs recognize E2,Ub conjugates (activated E2s) and use a region of E2s that had not before been implicated in Ub transfer. Based on these studies, a radically new ''see-saw'' mechanism for Ub transfer was proposed for NEL-domain BELs [25] .
The most recent addition to the BEL family is the XL-box domain BEL, XopL, from Xanthomonas campestris pv. vesicatoria (Xcv), a pathogen of tomatoes and peppers [26] . The general architecture of XopL is similar to NEL domain E3s in that it contains an N-terminal domain of LRRs with homology to those of NEL LRRs. The C-terminal domain is a novel E3 ubiquitin ligase domain known as the XL-box. The LRR domain alone is required for suppressing ETI; however, the catalytic domain is required to cause disease in the plant [26] . The XL domain lacks Cys residues, suggesting they function in a mechanism similar to RING-type E3s. Some E2 residues that are absolutely required for RING and HECT function were also required for XopL function, but others were not [26] .
Is BEL Activity Regulated?
The activity of NEL domain E3s is negatively regulated by the LRR domain in the absence of their substrates, presumably to prevent premature autoubiquitination until they can productively engage their substrates [22, 23, 27] . The first NEL domain enzyme-substrate structure has been characterized [28] . The LRR of SspH1 binds the HR1b coiled-coil subdomain of PKN1. This report provides the first direct evidence that substrate engagement activates the catalytic activity of NELs. In this case, a straightforward ''displacement model'' between a linear PKN1 motif and the inhibitory residues within the NEL domain compete for binding to residues within the LRR [28] . As LRR domains are remarkably diverse scaffolds for protein-protein interactions, it remains to be tested if the SspH1-PKN1 paradigm will emerge as a universal mechanism for effector-substrate recognition and activation for BELs. Precise BEL-substrate interactions were recently shown to effect distinct outcomes in the Pst system. The R proteins Fen and Pto interact near the Ring domain of AvrPtoB, resulting in their ubiquitination and degradation [10] . Pto can also interact with an AvrPtoB domain distal to the Ring domain [29] . Binding at the distal domain allows Pto to evade ubiquitination by the AvrPtoB E3 ligase and to activate an ETI response.
Though they do not have a ubiquitin system, bacteria encode a wide variety of E3 ubiquitin ligases that are delivered into the host cells that they infect using specialized secretion systems. A trend among BELs is that while they possess little to no sequence homology with eukaryotic E3s, they often share structural similarity. Notable exceptions are NEL domain and XL-box BELs, suggesting the idea that there are structurally related NEL domain enzymes encoded by eukaryotes. Determining the spectrum of BEL substrates in their respective hosts is an achievable goal. The identification of the eukaryotic proteins that BELs target will increase our understanding of immune functions and provide insights to help combat infection.
